|
Parexel's Risk Based Monitoring Offering with CluePoints New Advanced Statistical Capabilities
Parexel its strategic collaboration with CluePoints, an industry leading provider of Risk Based Study Execution and Data Quality Oversight Software, to enhance overall...
|
|
AbbVie Announces FDA Lifts Partial Clinical Hold on Phase 3 trial Study of Venetoclax
AbbVie announced that the FDA has lifted the partial clinical hold placed on CANOVA , a Phase 3 trial evaluating venetoclax for the investigational treatment...
| |